BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3931224)

  • 1. Cytologic, immunologic, and clinical diversity in non-Hodgkin's lymphoma: therapeutic implications.
    Urba WJ; Longo DL
    Semin Oncol; 1985 Sep; 12(3):250-67. PubMed ID: 3931224
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic classification of leukemia and lymphoma.
    Foon KA; Todd RF
    Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the immunologic classification of leukemia.
    Foon KA; Gale RP; Todd RF
    Semin Hematol; 1986 Oct; 23(4):257-83. PubMed ID: 3095928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
    Poppema S; Timens W; Visser L
    Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
    [No Abstract]   [Full Text] [Related]  

  • 6. SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage.
    Knowles DM; Dodson L; Burke JS; Wang JM; Bonetti F; Pelicci PG; Flug F; Dalla-Favera R; Wang CY
    Am J Pathol; 1985 Sep; 120(3):356-70. PubMed ID: 2931028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
    Borowitz MJ; Croker BP; Metzgar RS
    Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell lymphomas.
    Wright DH
    Histopathology; 1986 Mar; 10(3):321-6. PubMed ID: 3516842
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of molecular genetics on the study of lymphoid neoplasia.
    Harris NL
    Lab Invest; 1985 Nov; 53(5):509-12. PubMed ID: 3932777
    [No Abstract]   [Full Text] [Related]  

  • 10. T-cell lymphomas: immunologic, histologic, clinical, and therapeutic analysis of 63 cases.
    Coiffier B; Berger F; Bryon PA; Magaud JP
    J Clin Oncol; 1988 Oct; 6(10):1584-9. PubMed ID: 3262720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance.
    Menon M; Drexler HG; Minowada J
    Leuk Res; 1986; 10(1):25-8. PubMed ID: 3080642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
    Lauder I; Bird CC; Child JA; Grigor I
    J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphocyte subpopulations in the peripheral blood during polychemotherapy of non-Hodgkin's lymphoma].
    Trepińska E; Burchardt K; Sokołowski K
    Pol Tyg Lek; 1985 Aug; 40(33):932-5. PubMed ID: 3877275
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibody patterns in cutaneous lymphoid infiltrates. Their possible relevance to the diagnosis and categorization of cutaneous lymphomas.
    McMillan EM
    Dermatol Clin; 1985 Oct; 3(4):593-603. PubMed ID: 2947768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The so-called immunologic classification of non-Hodgkin's malignant lymphoma].
    Bednár B
    Cesk Patol; 1975 Nov; 11(4):161-8. PubMed ID: 1082375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
    Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
    Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non T lymphoid cells can express T cell surface characteristics: normal, HCL, and a range of leukemic B cells express T cell antigens after appropriate in vitro stimulation.
    Worman CP; Mills KH; Cawley JC
    Semin Oncol; 1984 Dec; 11(4):401-4. PubMed ID: 6334367
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.
    Picker LJ; Weiss LM; Medeiros LJ; Wood GS; Warnke RA
    Am J Pathol; 1987 Jul; 128(1):181-201. PubMed ID: 3111266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most null large cell lymphomas are B lineage neoplasms.
    Cleary ML; Trela MJ; Weiss LM; Warnke R; Sklar J
    Lab Invest; 1985 Nov; 53(5):521-5. PubMed ID: 3932778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic markers for classification of leukemias and non-Hodgkin lymphomas.
    Thierfelder S; Rodt H; Thiel E; Hoffmann-Fezer G; Netzel B; Haas RJ; Wündisch GF; Bender-Götze C
    Recent Results Cancer Res; 1979; 69():41-8. PubMed ID: 382307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.